Health Care Equipment & Services

TransMedics Group Inc. stays focused on transplant therapy for end‑stage organ failure, delivering solid financials and active industry engagement for investors.

XCELERATE INC’s stock volatility, negative PE/PB ratios and lack of recent updates signal a risky healthcare investment—learn what drives its current market valuation.

Read how PACS Group faces legal scrutiny after a resident’s death and the impact on safety protocols, investor sentiment, and regulatory action.

UHS CEO renewal fuels growth outlook: 10‑year returns, strong valuation, and expansion across U.S., U.K., Puerto Rico. Explore the future of Universal Health Services.

Elevance Health’s ELV stock climbs 1.92% in 2025, outpacing the S&P 500, while rising US health‑insurance premiums shape its pricing strategy and future growth outlook.

VentriPoint Diagnostics transforms ultrasound images into 3‑D heart models, rivaling MRI quality while lowering costs. Learn how its tech and market buzz could reshape cardiac diagnostics.

Discover how Nutex Health’s launch of Archview ER & Hospital fuels its $1.3 bn growth and reshapes U.S. health‑management, boosting investor confidence.

Abbott Laboratories: Diversified health‑care powerhouse with strong financials, global reach and a robust innovation pipeline driving growth in diagnostics, pharma and nutrition.

Explore SBC Medical Group’s bold $20 M share‑buyback and capital‑raising plan—how the company’s low P/E and blank‑check identity could reshape investor value and market confidence.

Agilon Health faces a Pomerantz investigation over alleged misrepresentations, sparking a 90 % share decline and prompting governance reforms.